Memorial Sloan Kettering Cancer Center

NCT07776613

Phase 2Recruiting202625 people20 Aug 2026clinicaltrials.gov

Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study

CollaboratorPhase 2Not yet recruiting202643 people23 Jun 2026clinicaltrials.gov

NCT07477457

Phase 2Recruiting202645 people17 Mar 2026clinicaltrials.gov

NCT07029217

Phase 3Recruiting2025375 people19 Jun 2025clinicaltrials.gov

NCT06903702

Phase 2Withdrawn20260 people1 Apr 2025clinicaltrials.gov

NCT06765317

Phase 2Recruiting202542 people9 Jan 2025clinicaltrials.gov

NCT06751589

Early phase 1Recruiting202436 people30 Dec 2024clinicaltrials.gov

NCT06528496

Phase 2Recruiting202445 people30 Jul 2024clinicaltrials.gov

NCT06377566

Phase 2Recruiting202471 people22 Apr 2024clinicaltrials.gov

NCT06083922

Phase 2Recruiting202320 people16 Oct 2023clinicaltrials.gov

NCT06057935

Phase 2Recruiting202364 people28 Sept 2023clinicaltrials.gov

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

No phaseRecruiting2023200 people28 Sept 2023clinicaltrials.gov

NCT05775094

Phase 1Active, not recruiting202310 people20 Mar 2023clinicaltrials.gov

NCT05736419

Phase 2Recruiting202324 people21 Feb 2023clinicaltrials.gov

NCT05491512

Phase 2Recruiting2022121 people8 Aug 2022clinicaltrials.gov

NCT05090358

Phase 2Active, not recruiting202115 people22 Oct 2021clinicaltrials.gov

NCT05081479

Phase 1Active, not recruiting20219 people18 Oct 2021clinicaltrials.gov

Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

Phase 2Recruiting202260 people5 Aug 2021clinicaltrials.gov

NCT04947501

Early phase 1Active, not recruiting202126 people1 Jul 2021clinicaltrials.gov

NCT04891289

Phase 2Recruiting2021164 people18 May 2021clinicaltrials.gov

Liquid biopsies reveal dual compartments of cancer risk from tumor and host-derived mutations

Bioinformatics (Oxford, England)24 Aug 2026